Extending varenicline preloading to 6 weeks facilitates smoking cessation: A single-site, randomised controlled trial
Background: Initiating varenicline use 4 weeks before the target quit date (TQD) reduces smoking in the run-in phase and increases end-treatment cessation rates; however, the lack of a smoke intake plateau suggests longer preloading periods are required. This study assessed whether varenicline prelo...
Main Authors: | Abraham Bohadana, Yossi Freier-Dror, Vardit Peles, Polina Babai, Gabriel Izbicki |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-02-01
|
Series: | EClinicalMedicine |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589537019302330 |
Similar Items
-
Pharmacological Basis of the Clinical Efficacy of Varenicline Used to Facilitate Smoking Cessation
by: S. R. Gilyarevskiy
Published: (2019-03-01) -
The place of varenicline in smoking cessation treatment.
by: Aveyard, P
Published: (2008) -
Nicotine preloading for smoking cessation: the Preloading RCT
by: Aveyard, P, et al.
Published: (2018) -
Smoking cessation 3: Nicotinic partial agonists in smoking cessation - Varenicline and cytisine
by: Aveyard, P, et al.
Published: (2009) -
Evaluation of Youtube content regarding Varenicline and smoking cessation
by: Musa SAHIN, et al.
Published: (2023-01-01)